Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trial

Authors

  • Simone Augustinus a Amsterdam UMC, Department of Surgery, University of Amsterdam, Amsterdam, TheNetherlands; b Cancer Center Amsterdam, Amsterdam, TheNetherlands
  • Thijmen Broekman b Cancer Center Amsterdam, Amsterdam, TheNetherlands; c Amsterdam UMC, Department of Medical Oncology, University of Amsterdam, Amsterdam, TheNetherlands
  • Geert-Jan Creemers d Department of Medical Oncology, Catherina Hospital, Eindhoven, The Netherlands
  • Lois A. Daamen e Division of Imaging & Oncology, University Medical Center Utrecht Cancer Center, Utrecht University, Utrecht, The Netherlands; f Department of Surgery, University Medical Center Utrecht Cancer Center, St Antonius Hospital Nieuwegein, Regional Academic Cancer Center Utrecht, University of Utrecht, Utrecht, The Netherlands
  • Susan van Dieren a Amsterdam UMC, Department of Surgery, University of Amsterdam, Amsterdam, TheNetherlands; b Cancer Center Amsterdam, Amsterdam, TheNetherlands
  • Jan-Willem B. de Groot g Department of Medical Oncology, Oncology Center Isala, Zwolle, The Netherlands
  • Geert A. Cirkel h Department of Medical Oncology, Regional Academic Cancer Center Utrecht, Meander Medisch Centrum, Amersfoort, The Netherlands
  • Marjolein Y. V. Homs i Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands
  • Hanneke W. M. van Laarhoven b Cancer Center Amsterdam, Amsterdam, TheNetherlands; c Amsterdam UMC, Department of Medical Oncology, University of Amsterdam, Amsterdam, TheNetherlands
  • Lobke van Leeuwen j Department of Medical Oncology, Regional Academic Cancer Center Utrecht, Diakonessenhuis, Utrecht, The Netherlands
  • Maartje Los k Department of Medical Oncology, Regional Academic Cancer Center Utrecht, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands
  • Saskia A. C. Luelmo l Department of Medical Oncology, Leids Universitair Medisch Centrum, Leiden, The Netherlands
  • Martijn G. H. van Oijen b Cancer Center Amsterdam, Amsterdam, TheNetherlands; c Amsterdam UMC, Department of Medical Oncology, University of Amsterdam, Amsterdam, TheNetherlands
  • Leontine E. A. M. Spierings m Department of Medical Oncology, Alrijne Ziekenhuis, Leiderdorp, The Netherlands
  • Judith de Vos-Geelen n Department of Medical Oncology, GROW, Maastricht UMC, Maastsricht, The Netherlands
  • Marc G. Besselink a Amsterdam UMC, Department of Surgery, University of Amsterdam, Amsterdam, TheNetherlands; b Cancer Center Amsterdam, Amsterdam, TheNetherlands
  • Johanna W. Wilmink b Cancer Center Amsterdam, Amsterdam, TheNetherlands; c Amsterdam UMC, Department of Medical Oncology, University of Amsterdam, Amsterdam, TheNetherlands

DOI:

https://doi.org/10.1080/0284186X.2023.2273898

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2023-12-02

How to Cite

Augustinus, S., Broekman, T., Creemers, G.-J., Daamen, L. A., van Dieren, S., de Groot, J.-W. B., … Wilmink, J. W. (2023). Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trial. Acta Oncologica, 62(12), 1973–1978. https://doi.org/10.1080/0284186X.2023.2273898

Issue

Vol. 62 No. 12 (2023): Acta Oncologica

Section

Articles